Stories > ADvantage Therapeutics Appoints Professor Kuro-o and Provides Updates on Alzheimer's Disease Compound

ADvantage Therapeutics Appoints Professor Kuro-o and Provides Updates on Alzheimer's Disease Compound

AMX0035 for PSP: Phase 3 Trial Commences

Advancements in Cancer Treatment and Mar...

Alpha Cognition's Business Update

ADOCIA Files 2023 Registration Document

AI Partnerships Drive Drug Discovery

ANJESO Drug Insight and Market Forecast